Research programme: antifungals - Microbia

Drug Profile

Research programme: antifungals - Microbia

Alternative Names: Anti-Invasins; Antifungals research programme - Microbia; MM-86553

Latest Information Update: 17 Sep 2007

Price : $50

At a glance

  • Originator Whitehead Institute for Biomedical Research
  • Class Small molecules
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Aspergillosis; Candidiasis; Mycoses

Most Recent Events

  • 25 Sep 2003 Data presented at the 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC-2003) have been added to the Antibacterials antimicrobial activity section ,
  • 12 Jun 2003 Preclinical trials in Candidiasis in USA (unspecified route)
  • 12 Jun 2003 Preclinical trials in Aspergillosis in USA (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top